AIM Companies Announce Positive News This Week
The good news keeps coming this week for our AIM companies, highlighting the compelling value on offer. As investors wake up to this, share values in the right companies are likely to rise. Here are some notable updates from our AIM companies:
Jet2 (AIM:JET2)
Shares in Jet2 surged 14% following a promising trading update and news of a substantial share buyback. Management is guiding to a profit of between £565m and £570m for the financial year ending March 2025, up 9% from the prior year. With total cash at £3.2bn and ‘Own Cash’ at £1.1bn, Jet2 is launching a £250m share buyback.
Elixirr International (AIM:ELIX)
Elixirr International announced excellent full-year results, pushing shares higher. Revenue rose 30% to £111.3m, with adjusted profit before tax climbing 22% to £29.7m. The first quarter of 2025 saw record revenue, and April is expected to be another record month.
CVS (AIM:CVSG)
CVS shares climbed 13% following a favourable outcome from the CMA review of the UK veterinary sector. The CMA’s review proposes greater transparency on medicine prices and alternatives, benefiting CVS’s recent sale of its crematoria operations.
GlobalData (AIM:DATA)
Shares in GlobalData jumped 26% on news of a potential takeover offer from private equity giants ICG and KKR. Preliminary discussions are underway, with no firm price agreed yet. As the company was due to leave AIM for the main market anyway, the price rise is welcome.
Conclusion
One good week does not repair the falls in AIM on its own, but positive results from the majority of our AIM companies point to the excellent value on offer which can help build momentum. If investors are starting to look favourably at AIM again, as recent share price increases suggest, portfolio values are likely to rise – finally.
More information
Fundamental Asset Management have been investing in AIM for IHT since 2004. If you or your adviser would like to speak investing in the AIM IHT Growth Portfolio or AIM IHT Income Portfolio, please email [email protected] or call 01923 713 890.
